PlatinumRx, a Bengaluru-based online pharmacy and healthcare platform, just got $6 million in funding led by Stellaris Venture Partners, with help from existing investor India Quotient. They had an earlier $800K funding round, and with this new money, PlatinumRx is ready to grow fast in India’s direct-to-consumer healthcare and wellness scene.
They’re going to use the funds to make their business stronger, open new fulfillment centers, and grow their product and tech teams. PlatinumRx wants to provide affordable, high-quality medicine all over the country.
Founded in 2023 by Ashutosh Pandey and Piyush Kumar, PlatinumRx is focused on being a digital-first healthcare brand that provides both online pharmacy services and tele-consultations. They specialize in offering substitute medicines, which have the same ingredients and strength as top brands, but cost patients 50–60% less. This approach is gaining PlatinumRx attention in the direct-to-consumer industry, setting them up as a competitor with brands like Tata 1mg, PharmEasy, Netmeds, and Apollo.
PlatinumRx has two fulfillment centers in Bengaluru and Delhi and plans to add five more in the next 12–18 months, to speed up delivery and reach more of the country. They already serve over two lakh patients across 20,000 pin codes, with one-day delivery in big cities and 3–5-day delivery elsewhere. They want to cut delivery times even more and reach more people.
Ashutosh Pandey, co-founder of PlatinumRx, said that the company wants to make medicine affordable without cutting corners on quality. He said they want people to be able to buy the same medicine from a different brand, while making sure the quality is top-notch. Because of their quality checks and return policies, PlatinumRx is focused on being a reliable healthcare brand, prioritizing trust, accessibility, and consumer well-being.
PlatinumRx shows how D2C wellness startups and premium brands are becoming more important in healthcare. While a lot of direct-to-consumer news has been about fashion, personal care, and food, healthcare is now becoming a driver of the direct-to-consumer market in India. Investors think platforms like PlatinumRx will change how medicine is distributed in India, thanks to consumer demand and the move towards digital healthcare.
As funding rounds keep happening in 2025, PlatinumRx’s growth shows the opportunities in the direct-to-consumer market. With its focus on affordability, quality, and getting bigger, the company is becoming one of the fastest-growing healthcare brands .
